Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen to Provide Ingenuity Systems IPA to Service Customers

NEW YORK, April 11 (GenomeWeb News) - Asuragen will provide the Ingenuity Pathway Analysis software to its molecular diagnostics service customers, Ingenuity Systems said today.

 

Asuragen, a spin-off from Ambion, will provide version 3.0 of the software for mRNA expression profiling to customers of its services business.

 

The company, comprised of Ambion's former diagnostics and services division as well as a discovery group, focuses on microRNAs as cancer diagnostics. Asuragen was formed after Applied Biosystems acquired Ambion's RNA business in March.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.